Mastectomy 16gene.html (article) 16gene.html

Slides:



Advertisements
Similar presentations
Breast Cancer. Dr. Swapna Chaudhary M.S. (MUM) M.S. (MUM) Consultant Obstetrician & Gynaecologist Infertility Specialist.
Advertisements

Interviewing Techniques as Tools for Diagnosis and Treatment, part 3 The Helpful Interview The Practice of Medicine -1 Christine M. Peterson, M.D.
Controversies in Breast Cancer Allan Arkush, DO, FACOS.
Mammogram’s Role as Savior Is Tested TARA PARKER-POPE New York Times, October 24, 2011
Princess Alexandra Hospitals NHS Trust Breast Unit Family History Clinic.
Breast Density A patient guide.
Objectives (BPS chapter 12)
Hereditary Factors in Breast Cancer
Breast Cancer Awareness October is Breast Cancer Awareness Month Submitted by Kadee Brousseau, Peer Advisor, University of Missouri.
Every Woman, Every Time: Disparities in Breast Cancer Tony L. Weaver, D.O. ALOMA 2015.
Breast Imaging Made Brief and Simple
Breast Screening. NHS Breast Screening Programme Introduced in 1988 Invites women from age group for screening every 3 yrs. Age extension roll-out.
Statistics: Unlocking the Power of Data Lock 5 STAT 250 Dr. Kari Lock Morgan Probability SECTIONS 11.1 Probability (11.1) Odds, odds ratio (not in book)
The Cancer Pedigree BRCA What?. Outline Introduction: Understanding the weight of genetics in Ovarian Breast Cancer BRCA 1 and BRCA 2 Genes – Function.
Probability and inference General probability rules IPS chapter 4.5 © 2006 W.H. Freeman and Company.
Conditional Probability and Screening Tests
Test Your Knowledge of Breast Cancer
5.3A Conditional Probability, General Multiplication Rule and Tree Diagrams AP Statistics.
Outcomes of screening mammography among women aged 40 to 43 Institute for Clinical Evaluative Sciences Toronto, Canada (2006)
Atoosa Adibi MD. Department of Radiology Isfahan University Of Medical Sciences.
Breast Cancer Methods for Early Detection. Breast Cancer What It Is Methods of Early Detection Risk Factors.
EPIB-591 Screening Jean-François Boivin 29 September
Incidence of and Risk Factors for Sudden Cardiac Death in Children with Dilated Cardiomyopathy: A Report from the Pediatric Cardiomyopathy Registry Elfriede.
Kalavathy Mathur chennath 1, Meera Radhakrishnan 1 Assistant Professor Regional Cancer Centre Trivandrum Kerala, India.
INCIDENCE AND SURVIVAL TRENDS OF COLORECTAL CANCER FROM 2002 TO 2011 BE Ansa; E Alema-Mensah; MD Claridy; JQ Sheats; B Fontenot, and SA Smith Georgia Regents.
Probability and inference General probability rules IPS chapter 4.5 © 2006 W.H. Freeman and Company.
1/20 Remco Chang (Computer Science) Paul Han (Tufts Medical / Maine Medical) Holly Taylor (Psychology) Improving Health Risk Communication: Designing Visualizations.
Metabolic Syndrome and Recurrence within the 21-Gene Recurrence Score Assay Risk Categories in Lymph Node Negative Breast Cancer Lakhani A et al. Proc.
Probability and inference General probability rules IPS chapter 4.5 © 2006 W.H. Freeman and Company.
Breast Complaints You gotta know when to screen em, know when to street em, know when to reassure, know when to refer.
Shiva Sharma SHO to Professor Redmond.  Introduction  Increased risk groups  Consideration of genetic testing  Management of patients with mutation.
How will you approach the 35-year old, with a 2x2x2cm, firm, mobile, well-circumscribed non-tender mass on her R breast?
Be Clear on Cancer: Breast Cancer in Women 70+ North Trent Cancer Network.
REACH Lay Health Worker Intervention Program: A Community-Based Model to Promote Breast Cancer Screening Among Vietnamese-American Women Gem M. Le, MHS.
During this presentation the learner will be able to: 1. Understand current breast cancer screening guidelines for mammography. 2. Compare and contrast.
Breast Cancer Prevention Art or Science? Kristi McIntyre M.D. Texas Oncology 2005.
Screening and its Useful Tools Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
BREAST CANCER: Half a million women later… Amy Miglani M.D September 3, 2004.
Positive Predictive Value and Negative Predictive Value
PAIN CONTROL AMONG CANCER SURVIVORS IN OHIO 2010 Robert W. Indian, Chief Mary Lynn, Researcher Debbie Wallace, Administrative Assistant Comprehensive Cancer.
Unit 15: Screening. Unit 15 Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Effect of process indicators on the episode sensitivity of mammography Tytti Sarkeala, MSc Finnish Cancer Registry Ahti Anttila Matti Hakama Irma Saarenmaa.
HEAPHY 1 & 2 CASE RACE 1 – DIAG Yvonne CLARKE Sat 31 st Aug 2013 Session 3 / CR1-4 13:16 – 13:20 WELLINGTON ABSTRACT Following a woman’s pathway from her.
Upon completion of this lesson, you will be able to: Identify different diagnostic procedures for breast cancer screening Describe different diagnostic.
Breast Cancer Surveillance Consortium (BCSC): A Research Infrastructure sponsored by the National Cancer Institute Breast Cancer Risk Models William Barlow,
Clinical Outcome of Reconstruction With Tissue Expanders for Patients With Breast Cancer and Mastectomy Mitsui Memorial Hospital Department of Breast and.
This material is protected by United States copyright law, and includes content owned by Discovery Education, The Val Skinner Foundation, and Rutgers,
Date of download: 2/26/2013 Copyright © 2012 American Medical Association. All rights reserved. From: Incidence of Breast Cancer With Distant Involvement.
Kevin S.Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Surgeon The Newton-Wellesley Hospital.
BC Cancer Agency CARE & RESEARCH Breast Cancer Mortality After Screening Mammography in British Columbia Women Andrew J. Coldman, Ph.D. Norm Phillips,
Breast cancer facts Daniela Cazares. Fact #1 In the US, 1 in 8 women will be diagnosed with breast cancer in their lifetime.
Let’s fight breast cancer starting with you.. You can fight breast cancer by being educated.
HL2 Math - Santowski Lesson 93 – Bayes’ Theorem. Bayes’ Theorem  Main theorem: Suppose we know We would like to use this information to find if possible.
Methods Background Abstract Probability Parameters Selected References Genetic testing for BRCA mutations in high-risk women is cost-effective under base-
© Copyright Annals of Internal Medicine, 2016 Ann Int Med. 164 (6): ITC6-1. In the Clinic Breast Cancer Screening and Prevention.
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Date of download: 7/7/2016 From: Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review.
Is suicide predictable? Paul St John-Smith Short Courses in Psychiatry 15/10/2008.
U NIT 5: P ROBABILITY —W HAT ARE THE C HANCES ? (P ULL OUT YOUR FORMULA SHEET )
Evidence for Autosomal Dominant Inheritance of Prostate Cancer
What do Women Know About Breast Density?
Optimal Ways to learn about and communicate Evidence Based Medicine

Michael S. Bloom, PhD, Zheng Hu, MS, Joel C. Gaydos, MD, John F
Breast Health Katherine B. Lee, MD, FACP April 26, 2018.
Medical Diagnosis Problem
Presenter: Wen-Ching Lan
Breast Cancer Screening Rates Highest in Sweden and the U.S.
Evidence for Autosomal Dominant Inheritance of Prostate Cancer
Evidence Based Diagnosis
Presentation transcript:

Mastectomy 16gene.html (article) 16gene.html health/ /the-story-of-a- previvor.html (video) health/ /the-story-of-a- previvor.html 0/2/77 (New England Journal of Medicine) 0/2/77

New England Journal of Medicine Volume 340:77-84January 14, 1999Number 2 Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer Lynn C. Hartmann, M.D., Daniel J. Schaid, Ph.D., John E. Woods, M.D., Thomas P. Crotty, M.D., Jeffrey L. Myers, M.D., P.G. Arnold, M.D., Paul M. Petty, M.D., Thomas A. Sellers, Ph.D., Joanne L. Johnson, R.N., Shannon K. McDonnell, M.S., Marlene H. Frost, Ph.D., R.N., Robert B. Jenkins, M.D., Ph.D., Clive S. Grant, M.D., and Virginia V. Michels, M.D. ABSTRACT Background Options for women at high risk for breast cancer include surveillance, chemoprevention, and prophylactic mastectomy. The data on the outcomes for surveillance and prophylactic mastectomy are incomplete. Methods We conducted a retrospective study of all women with a family history of breast cancer who underwent bilateral prophylactic mastectomy at the Mayo Clinic between 1960 and The women were divided into two groups — high risk and moderate risk — on the basis of family history. A control study of the sisters of the high-risk probands and the Gail model were used to predict the number of breast cancers expected in these two groups in the absence of prophylactic mastectomy. Results We identified 639 women with a family history of breast cancer who had undergone bilateral prophylactic mastectomy: 214 at high risk and 425 at moderate risk. The median length of follow-up was 14 years. The median age at prophylactic mastectomy was 42 years. According to the Gail model, 37.4 breast cancers were expected in the moderate- risk group; 4 breast cancers occurred (reduction in risk, 89.5 percent; P<0.001). We compared the numbers of breast cancers among the 214 high-risk probands with the numbers among their 403 sisters who had not undergone prophylactic mastectomy. Of these sisters, 38.7 percent (156) had been given a diagnosis of breast cancer (115 cases were diagnosed before the respective proband's prophylactic mastectomy, 38 were diagnosed afterward, and the time of the diagnosis was unknown in 3 cases). By contrast, breast cancer was diagnosed in 1.4 percent (3 of 214) of the probands. Thus, prophylactic mastectomy was associated with a reduction in the incidence of breast cancer of at least 90 percent. Conclusions In women with a high risk of breast cancer on the basis of family history, prophylactic mastectomy can significantly reduce the incidence of breast cancer.

Problems with Prob Franklin’s Law Miscommunication of risk Clouded thinking

Tests Reality Test YesNo Yes Hit False positive No Miss Correct rejection

Bayes Rule

For symptom-free women aged 40 to 50 who participate in screening using mammography, the following information is available for this region. The probability that one of these women has breast cancer is 0.8%. If a woman has breast cancer, the probability is 90% that she will have a positive mammography test. If a woman does not have breast cancer, the probability is 7% that she will still have a positive mammography test. What is the probability that a woman with a positive test actually has breast cancer? For symptom-free women aged 40 to 50 who participate in screening using mammography, the following information is available for this region. Out of 1000 women 8 will have breast cancer. Of these 8 women, 7 will have a positive mammograms. Of the remaining 992 women, 70 will have a positive mammogram. What is the probability that a woman with a positive test actually has breast cancer?

The probability that a given person has disease A is 1%. If the person has disease A, then a particular test will be positive 95% of the time. If a person does not have disease A, then the test will be positive only 4% of the time. If a person has a positive test result, what are the odds, he actually has the disease? The probability that a given person is lying is 4%. If the person has lies, then a lie detector test will be positive 99% of the time. If a person does not lie, then the lie detector test will be positive only 10% of the time. If a lie detector indicates a person is lying, what are the odds, he is lying?

1000 Telling Truth Lying Positive Test Negative Test Positive Test Negative Test